AzTrials
AzTrials

Executive Function of School-aged Children With ASDNCT06130293

VR Executive Training of School-aged Children With ASD

A study testing VR game intervention in people with Executive Function of School-aged Children With ASD, run by National Taiwan Normal University at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Many studies support that children with autism spectrum disorder (ASD) show executive dysfunction. The applicant's NSC project report also indicated that in all areas in the behavior rating inventory of executive function, the second edition (BRIEF-2), including inhibit, self-monitor, shift, emotional control… Read more about this study

Who is it for?
Ages 6 to 12 years
What is being tested?
VR game intervention
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTaiwan
Study dates
31 Oct 2023to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • diagnosed with ASD by a qualified healthcare professional
  • meeting the ASD criteria by using ADOS-2
  • IQ higher than 80.

Who cannot join

  • not meeting the ASD criteria by using ADOS-2.
  • IQ lower than 80.
  • comorbid physical and/or motor disabilities.
  • comorbid mental disabilities except ADHD.

Trial locations and contacts

1 site in 1 country.

Meng-Ting Chen, PhD contact

+886-2-77493786

montine@gapps.ntnu.edu.tw

Taiwan1 site, 1 recruiting
  • National Taiwan Normal University

    Taipei, State, 106010

    Meng-Ting Chen, +886939605325, montine@gapps.ntnu.edu.tw

    montine@gapps.ntnu.edu.tw

    Recruiting

Other trials in Taiwan

About this study

Official title: The Effect of Daily Executive Function Training in School-aged Children With Autism Spectrum Disorder

Many studies support that children with autism spectrum disorder (ASD) show executive dysfunction. The applicant's NSC project report also indicated that in all areas in the behavior rating inventory of executive function, the second edition (BRIEF-2), including inhibit, self-monitor, shift, emotional control, initiate, working memory, plan/organize, task-monitor, and organization of materials, children in the typically developmental group showed better performance than children in the ASD group. The results also indicated that compared to the diagnosis of ASD, an executive function could be a better predictor of daily life adaptation. Similarly, more and more researchers put their efforts into executive training. However, the results are mixed. A meta-analysis showed that technology-based training can effectively improve the executive function of children with ASD. Children with ASD love game-like training as it provides friendly environments to children with ASD and induces less anxiety. The applicant, therefore, plans to develop a virtual reality executive function training program in the first year based on the applicant's previous experience with executive function training. The game will include the components of visual searching, reaction time, shift, planning, and working memory. At the end of the game, the game will provide visual feedback to the children to train in self-monitoring. In the second year, the applicant will conduct a randomized controlled trial to investigate the effectiveness of the training program. I plan to include 70 children with ASD and randomly assign them to either the executive training or control groups. Executive function and daily life adaptation will be the indexes of the effectiveness of the study.

Being tested
VR game intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VR game interventionDevice

    Using self-paced VR game to train.

Study groups in NCT06130293
Study groupRoleWhat they receive
VR trainingExperimentalUsing VR training. 40 minutes per session, one session per week, and a total 8 weeks.
Receives: Device: VR game intervention
Waiting list groupNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Questionnaire of executive function

    parent's and teacher's forms

    Measured: Week 0 (pre-intervention), Week 9 (post-intervention), and follow-up (Week 18 to Week 26)

Secondary outcomes (1)
  1. Questionnaire of adaptive behaviors

    parent's and teacher's forms

    Measured: Week 0 (pre-intervention), Week 9 (post-intervention), and follow-up (Week 18 to Week 26)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2023
  2. Study start31 Oct 2023
  3. Primary completion31 Oct 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06130293
Sponsor's protocol ID
202310HM006
Status last verified
Nov 2023
First submitted
6 Nov 2023
Last updated
14 Nov 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing VR game intervention in people with Executive Function of School-aged Children With ASD, run by National Taiwan Normal University at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 14 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Meng-Ting Chen, PhD (+886-2-77493786, montine@gapps.ntnu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Questionnaire of executive function (time frame: Week 0 (pre-intervention), Week 9 (post-intervention), and follow-up (Week 18 to Week 26)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Nov 2023; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in